New Heart Failure Guidelines Released, but Are They Already Out of Date? Results of EMPEROR-Preserved contradict guidance Aug 27, 2021
Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozin DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits Aug 27, 2021
Heart Failure Again Takes Center Stage at ESC EMPEROR-Preserved, new guidelines, and more to come Aug 26, 2021
More and More U.S. Kids Being Diagnosed With Diabetes Rises seen in both type 1 and type 2 diabetes Aug 24, 2021
Combo GIP/GLP-1 Injectable Beats Insulin for A1c Reduction All doses of once-weekly tirzepatide better than insulin degludec for HbA1c reduction Aug 11, 2021
U.S. Kids Chowed Down on Highly Processed Foods Majority of energy intake came from ready-to-eat, ultraprocessed foods in 1999-2018 Aug 10, 2021
Anti-VEGF Injections Preserved Vision in Severe Diabetic Retinopathy Aflibercept also reduced vision-threatening complications Aug 05, 2021
FDA OKs First Interchangeable Insulin Biosimilar Semglee and Lantus insulin glargine products can now be swapped by pharmacists Jul 29, 2021
SGLT2 Inhibitor Adds Years of Life to Patients With Heart Failure DAPA-HF group makes projections as long-term data are lacking Jul 28, 2021
Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits More insight into mechanisms behind empagliflozin's cardioprotection Jul 26, 2021
Doubling Semaglutide Dose Helps Get HbA1c Under Control But when is it time to add another agent to the mix? Jul 22, 2021
Spinal Cord Stimulation OK'd for Diabetic Nerve Pain First device of its kind to gain FDA approval for painful diabetic neuropathy Jul 19, 2021
Dexcom's CGM Interoperability Expands; Warfarin and Osteoporosis; Maine Bans PFAS News and commentary from the endocrinology world Jul 18, 2021
Academic Cardiologists Singled Out for Gender Equality Problem Women still poorly represented, paid in procedural internal medicine specialties Jul 12, 2021
Walmart's Low-Price Insulin Is a Band-Aid on a Broken System Exorbitant drug pricing and inaccessible care require government intervention Jul 11, 2021
Finerenone OK'd for Slowing Kidney Disease in T2D Drug also indicated for cardiovascular event risk reduction Jul 09, 2021
A Day in the Life of a Doctor: ICU Night Shift Follow YouTuber Siobhan Deshauer, MD, as she navigates a patient's cardiac arrest. Jul 02, 2021
CDC Study: Income-Related Inequalities Widening in Diabetes Disparities differed by sex and age group Jul 01, 2021
ADA 2021 Roundup: SoliMix Trial; Byetta for Teens; Driving in Hypoglycemia Noteworthy research from the American Diabetes Association virtual meeting Jun 30, 2021
Genetics, Socioeconomic Factors Each Tied to Diabetes and Obesity People with highest risk genetics more than 15 times more likely to have T2D Jun 30, 2021
Liraglutide and Insulin Come Out on Top for Glycemic Control in GRADE study Head-to-head comparison could help individualize treatment Jun 29, 2021
Resmetirom Delivers Promising Outcomes in NASH Without Invasive Follow-Up Real-world study also identifies noninvasive markers for treatment response Jun 29, 2021
Investigational GLP-1 RA Cuts Heart, Renal Risk in Vulnerable Diabetes Patients Exendin-4-based drug succeeded in cardiovascular outcomes trial Jun 28, 2021
180-Day Continuous Glucose Monitor Shows Promise in Adults With Diabetes Implantable Eversense system demonstrates accuracy in prospective study Jun 28, 2021
Hospitalization Rates for New-Onset Type 2 Diabetes in Kids Took Off During Pandemic "COVID-19 disrupted our lives in more ways than we realize" Jun 26, 2021
Combo GIP/GLP-1 Drug Superior for HbA1c Reduction in T2D 40-week trial compared tirzepatide head-to-head with injectable semaglutide Jun 25, 2021
'Modest' Erectile Dysfunction Benefit With GLP-1 Agonist Dulaglutide didn't improve pre-existing symptoms, but did prevent some new cases Jun 23, 2021
Best Pediatric Endocrinology Hospitals; Standards of Diabetes Care Updated News and commentary from the endocrinology world Jun 20, 2021
What Leads to Patients With Diabetes Relapsing After Bariatric Surgery? Risk factors included longer diabetes duration, higher preop HbA1c in Swedish study Jun 14, 2021
Nearly a Five-Fold Difference Between States in Use of Bariatric Surgery Weight loss procedure underutilized in areas with highest obesity prevalence Jun 13, 2021
Patients with Class I Obesity Still Benefit from Weight-Loss Surgery It may be time to update NIH-established indications for bariatric surgery, experts say Jun 12, 2021
Heart Risk With Gender-Affirming Tx; Burden of Thyroid Eye Disease; T1D Care Gaps More notable research from the AACE 2021 virtual meeting Jun 01, 2021
High Frequency Spinal Stimulation Succeeds in Diabetic Neuropathy Pain relief was significant and durable in SENZA-PDN trial May 29, 2021
COVID-19 in Diabetes: What Mediates Risk? Certain clinical factors tied to higher chance of severe infection May 28, 2021
Op-Ed: Let's Stop Equating Female and Male Bodies Medical tech needs to account for how gender agnostic conditions affect women differently May 27, 2021
Getting Competitive Boosted Physical Activity in Diabetes Competing for top spot increased mean daily step counts in gamified study May 24, 2021
Op-Ed: Diabetes Is Not an Equal Opportunity Killer Policy change and community intervention can help fight disparities May 23, 2021
FDA Draft Guidance on T2D Devices; New GLP-1 Drug Succeeds in Trial News and commentary from the endocrinology world May 23, 2021
Finerenone May Delay AFib Onset in Patients With CKD and Diabetes Risk of kidney or CV events reduced regardless of atrial fibrillation or atrial flutter history May 18, 2021
DARE-19 Didn't Pay Off for Farxiga in COVID-19 But trial may still show SGLT2 inhibitor is safe for sicker patients May 17, 2021
